Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Masimo (MASI) Minority Interest (2010 - 2021)

Masimo's quarterly Minority Interest came in at -$20000.0 in Q1 2021, down 106.73% quarter-over-quarter from $297000.0 in Q1 2016.

Masimo has reported Minority Interest for 8 years, with the latest figure at -$20000.0 in Q1 2021.

For the quarter ending Q1 2021, Minority Interest changed N/A year-over-year to -$20000.0; the trailing twelve-month figure through Jan 2021 stood at -$20000.0 (changed N/A YoY), and the FY2021 full-year result was -$20000.0, changed N/A from the prior year.
Minority Interest for Q1 2021 stood at -$20000.0, down from $297000.0 in the prior quarter.
The five-year high for Minority Interest was -$20000.0 in Q1 2021, with the low at -$20000.0 in Q1 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	Masimo	9.32 Bn	9.20 Bn	250.80 Mn

Historic Data

Download Data 🔒

Date	Value
Jan 2, 2021	-20,000.00
Jan 2, 2016	297,000.00
Oct 3, 2015	-1.00 Mn
Jul 4, 2015	392,000.00
Apr 4, 2015	1.05 Mn
Jan 3, 2015	1.74 Mn
Sep 27, 2014	1.18 Mn
Jun 28, 2014	-96,000.00
Mar 29, 2014	-250,000.00
Dec 28, 2013	-68,000.00
Sep 28, 2013	59,000.00
Jun 29, 2013	174,000.00
Mar 30, 2013	2.56 Mn
Dec 29, 2012	2.59 Mn
Sep 29, 2012	2.73 Mn
Mar 31, 2012	2.85 Mn
Dec 31, 2011	2.84 Mn
Oct 1, 2011	2.46 Mn
Jul 2, 2011	2.45 Mn
Apr 2, 2011	2.56 Mn
Jan 1, 2011	2.39 Mn
Oct 2, 2010	1.85 Mn
Jul 3, 2010	1.56 Mn
Jan 2, 2010	974,000.00